Headline Roundup March 22, 2021
AstraZeneca Says Its COVID-19 Vaccine is 79% Effective
Summary from the AllSides News Team
Featured Coverage of this Story

The Washington Post
Oxford University and AstraZeneca reported on Monday that their coronavirus "vaccine for the world" was safe and 79 percent effective overall, according to data from a long-awaited clinical trial in the United States, alongside other studies in Chile and Peru. The two-shot regimen was completely effective at preventing severe cases of illness.
In a news release, the Oxford researchers, who developed the easily transported $4 shot for the British-Swedish pharmaceutical giant AstraZeneca, said their coronavirus vaccine is “safe and highly effective, adding to previous trial data from the United Kingdom,...

Associated Press
AstraZeneca’s COVID-19 vaccine provided strong protection against sickness and eliminated hospitalizations and deaths from the disease, including in older adults, in final-stage U.S. testing, the company announced Monday.
AstraZeneca said its experts did not identify any safety concerns related to the vaccine, including finding no increased risk of rare blood clots identified in Europe. The question now is whether the findings will help rebuild public confidence in the vaccine around the world, as the company seeks to win clearance in the United States
In a statement, AstraZeneca said its COVID-19...
_3.jpg)
Washington Examiner
New data from AstraZeneca’s coronavirus vaccine trial, which has yet to receive emergency authorization in the United States, is showing positive results.
The latest data from the company published on Monday showed that the vaccine has an efficacy of 79% at preventing symptomatic cases of the coronavirus while being 100% effective at stopping severe disease and hospitalization. The trial included 32,449 participants, and a fifth of them, approximately 8,000 people, were 65 years old or older. 60% of study participants have comorbidities that make them more at risk for a...
AllSides Picks
Blog
Media Bias Alert: DOJ Claims Biden Admin Weaponized Gov’t to ‘Chill Free Speech’ Despite Internal Dissent
Andy Gorel
October 8th, 2026
Red Blue Translator
Anti-vaxxer
Headline Roundup
Pollsters Face Obstacles as 2026 Midterms Approach
November 2nd, 2026
Blog
Villain or Hero? How the Left and Right Covered the Lone Holdout Juror in the Lindsay Clancy Trial
Jamie Krstev
November 3rd, 2026